bluebird bio, Inc.
BLUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $81 | $1,969 | $10,876 | $13,768 |
| - Cash | $62 | $222 | $113 | $161 |
| + Debt | $358 | $330 | $367 | $90 |
| Enterprise Value | $377 | $2,078 | $11,130 | $13,697 |
| Revenue | $84 | $29 | $4 | $4 |
| % Growth | 184.1% | 720% | -1.8% | – |
| Gross Profit | -$6 | -$4 | -$6 | -$35 |
| % Margin | -6.6% | -13.7% | -180.2% | -961.1% |
| EBITDA | -$157 | -$167 | -$216 | -$557 |
| % Margin | -187.1% | -566.7% | -5,992.7% | -15,208.2% |
| Net Income | -$241 | -$212 | -$230 | -$819 |
| % Margin | -287.2% | -718.4% | -6,403.7% | -22,375.2% |
| EPS Diluted | -24.84 | -2.97 | -3.39 | -8.16 |
| % Growth | -736.4% | 12.4% | 58.5% | – |
| Operating Cash Flow | -$260 | -$235 | -$353 | -$636 |
| Capital Expenditures | -$3 | -$9 | -$13 | -$23 |
| Free Cash Flow | -$263 | -$244 | -$366 | -$659 |